PALATIN TECHNOLOGIES INC

CRANBURY, NJ How do I update this listing?

Palatin Technologies is based out of Cranbury. Palatin Technologies is a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases. Co.'s programs are based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. Co.'s primary product in clinical development is bremelanotide for the treatment of female sexual dysfunction. In addition, Co. has drug candidates or development programs, which include: melanocortin receptor-based compounds under development by AstraZeneca AB for the treatment of obesity; and PL-3994, a peptide mimetic natriuretic peptide receptor A agonist for treatment of cardiovascular and pulmonary indications.Whalewisdom has at least 112 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2012-07-13. The notice included securities offered of Equity,Option, Warrant or Other Right to Acquire Another Security

Create Alert

Contact Info

palatin technologies inc
4B CEDAR BROOK DRIVE
CRANBURY NJ    08512

Business Phone: 609-495-2200
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2012-07-13 D PHARMACEUTICALS Equity,Option, Warrant or Other Right to Acquire Another Security 35,000,000 35,000,000 0
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
ALAN W. DUNTON subscription required
    DIRECTOR
CARL SPANA subscription required
    EXECUTIVE OFFICER DIRECTOR
JOHN K. A. PRENDERGAST subscription required
    DIRECTOR
JOSEPH STANLEY HULL subscription required
    DIRECTOR
PERRY B. MOLINOFF subscription required
    DIRECTOR
ROBERT K. DEVEER subscription required
    DIRECTOR
ROBERT I. TABER subscription required
    DIRECTOR
STEPHEN T. WILLS subscription required
    EXECUTIVE OFFICER
ZOLA P. HOROVITZ subscription required
    DIRECTOR

Elevate your investments